Home / Inspections / 1153395

FDA Inspection 1153395 — Bayer Healthcare Pharmaceuticals Inc.

Bayer Healthcare Pharmaceuticals Inc. — FEI 2243252

The FDA completed an inspection of Bayer Healthcare Pharmaceuticals Inc. on September 15, 2021 in Whippany, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 15, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Whippany, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1286004 (NAI Mon Oct 20 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1277153 (NAI Fri Aug 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1251837 (NAI Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1196111 (NAI Wed Feb 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1067092 (NAI Thu Aug 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources